SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sun Pharma to announce second quarter results on October 28, 202415-10-2024
15-10-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Issue of Letter of Confirmation11-10-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Update On Regulatory Order
Intimation regarding update on Regulatory Order11-10-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation regarding Compliance Certificate.10-10-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate.10-10-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Board Meeting Intimation for Approval Of Financial Results
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 ,inter alia, to consider and approve Financial Results for the quarter and half year ended September 30, 202409-10-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificate08-10-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regulatory Order
Intimation regarding order passed by Regulatory Authority07-10-2024
Sun Pharma, Philogen Enter Pact To Commercialise Cancer Medicine Fibromun
Sun Pharma and Philogen will share post-commercialisation economics in a 45 (Philogen):55 (Sun Pharma) ratio.01-10-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Sun Pharma and Philogen enter into a global Exclusive Commercialization, License and supply agreement for commercializing the speciality product FIBROMUN01-10-2024